Quality of life measurements do not support palliative pancreatic cancer treatments

International Journal of Oncology

Volumn 13, Issue 6, 1998, Pages 1323-1329

  Kokoska, Evan R ^b   Stapleton, Diane R ^a   Virgo, Katherine S ^b   Johnson, Frank E ^b,c   Wade, Terence P ^a,b  

^a Scott AFB   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Chemotherapy; Palliation; Pancreatic cancer; Quality of life; Radiation therapy; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SURVIVAL RATE;

EID: 0031742712     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.6.1323     Document Type: Article

References (33)

1. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics, 1997. CA 47: 5-27, 1997.
2. Trede M, Schwall G and Saeger H: Survival after pancreatoduodenectomy - 118 consecutive resections without an operative mortality. Ann Surg 211: 447-458, 1990.
3. Geer RJ and Brennan MF: Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165: 68-74, 1993.
4. Gall FP, Kessler H and Hermanek P: Surgical treatment of ductal pancreatic carcinoma. Eur J Surg Oncol 17: 173-181, 1991.
5. Yeo CJ, Cameron JL, Lillemoc KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J and Pitt HA: Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221: 721-733, 1995.
6. Nitecki SS, Sarr MG, Colby TV and van Heerden JA: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221: 59-66, 1995.
7. Feduska NJ, Dent TL and Lindenauer SM: Results of palliative operations for carcinoma of the pancreas. Arch Surg 103: 330-334, 1971.
8. Yasue M, Sakamoto J, Morimoto T, Yasui K, Kuno N, Kurimoto K, Teramukai S and Ohashi Y: Evaluation of the effect of pancreatic resection in advanced pancreatic cancer with special reference using hospital-free survival as a measure of quality of life. Jpn J Clin Oncol 25: 37-45, 1995.
9. Johnson CD: Palliative resection of pancreatic adenocarcinoma. HPB Surg 8: 181-183, 1995.
10. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeef A, Sauter PK, Hruban RH, Abrams RA and Pitt HA: Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg 223: 718-728, 1996.
11. Bakkevold KE and Kambestad B: Palliation of pancreatic cancer, a prospective multicentre study. Eur J Surg Oncol 21: 176-182, 1995.
12. McLeod RS, Taylor BR, O'Connor BI, Greenberg GR, Jeejeebhoy KN, Royall D and Langer B: Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 169: 179-185, 1995.
13. Ghosh BC and Jaklic B: Military's role in the war against cancer: an expanding horizon. J Surg Oncol 56: 145, 1994.
14. Karnofsky DA and Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of Chemotherapeutic Agents. MacLeod CM (ed). Columbia University Press, New York, pp191-205, 1949.
15. Yates JW, Chalmer B and McKegncy FP: Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45: 2220-2224, 1980.
16. Mor V, Chalmer B, Morris JN and Weimann M: The Karnofsky performance status scale; an examination of its reliability and validity in a research setting. Cancer 53: 2002-2007, 1984.
17. Schag CC, Heinrich R and Ganz PA: Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2: 187-193, 1984.
18. Boyle CA and Decoufle P: National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol 131: 160-168, 1990.
19. Wade TP, Radford DM, Virgo KS and Johnson FE: Treatment of pancreatic adenocarcinoma in the U.S. veteran: complications and outcomes. J Am Coll Surg 179: 38-48, 1994.
20. Harrison LE, Klimstra DS and Brennan MF: Isolated portal vein involvement in pancreatic adenocarcinoma. Ann Surg 224: 342-349, 1996.
21. Hoffman JP, Weese JL, Solin LJ, Engstrom P, Agarwal P, Barber LW, et al: A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg 169: 71-78, 1995.
22. Soybel DI: Pancreaticoduodenectomy and palliation in pancreatic carcinoma. Gastroenterology 122: 1046-1048, 1997.
23. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, et al: Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161: 120-125, 1991.
24. Delcore R, Rodriguez FJ, Forster J, Hermreck AS and Thomas JH: Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg 172: 463-469, 1996.
25. Wade TP, El-Ghazzawy AG, Virgo KS and Johnson FE: The Whipple resection for cancer in US Department of Veterans Affairs hospitals. Ann Surg 221: 241-248, 1995.
26. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59: 2006-2010, 1987.
27. Glimelius B, Hoffman K, Sjoden PO, Jacobsson G, Sellstrom H, Enander LK, Linne T and Svensson C: Chemotherapy improves survival. Oncology 7: 593-600, 1996.
28. Moertel CG, Childs DS, Reitmeier RJ, Colby MY and Holbrook M: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet ii: 865-867, 1969.
29. Moertel CG, Frytak S, Hahn RG, et al: Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads) + 5-fluorouracil, and high dose radiation + 5-fluorouracil: the gastrointestinal tumor study group: Cancer 48: 1705-1710, 1981.
30. Schaafsma J and Osoba D: The Karnofsky performance status scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res 3: 413-424, 1994.
31. Grieco A and Long CJ: Investigation of the Karnofsky performance status as a measure of quality of life. Health Psychol 3: 129-142, 1984.
32. Taylor KM, Macdonald KG, Bezjak A, Ng P and De Petrillo AD: Physicians' perspective on quality of life: an exploratory study of oncologists. Qual Life Res 5: 5-14, 1996.
33. Ringdal GI, Gotestam KG, Kaasa S, Kvinnsland S and Ringdal K: Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer 73: 1594-1599, 1996.